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Background: Disrupted sleep is common among nursing home patients with dementia
and is associated with increased agitation, depression, and cognitive impairment.
Detecting and treating sleep problems in this population are therefore of great
importance, albeit challenging. Systematic observation and objective recordings of sleep
are time-consuming and resource intensive and self-report is often unreliable. Commonly
used proxy-rated scales contain few sleep items, which affects the reliability of the raters’
reports. The present study aimed to adapt the proxy-rated Sleep Disorder Inventory (SDI)
to a nursing home context and validate it against actigraphy.
Methods: Cross-sectional study of 69 nursing home patients, 68% women, mean
age 83.5 (SD 7.1). Sleep was assessed with the SDI, completed by nursing home
staff, and with actigraphy (Actiwatch II, Philips Respironics). The SDI evaluates the
frequency, severity, and distress of seven sleep-related behaviors. Internal consistency
of the SDI was evaluated by Cronbach’s alpha. Spearman correlations were used to
evaluate the convergent validity between actigraphy and the SDI. Test performance was
assessed by calculating the sensitivity, specificity, and predictive values, and by ROC
curve analyses. The Youden’s Index was used to determine the most appropriate cut-off
against objectively measured sleep disturbance defined as <6 h nocturnal total sleep
time (TST) during 8 h nocturnal bed rest (corresponding to SE <75%).
Results: The SDI had high internal consistency and convergent validity. Three SDI
summary scores correlated moderately and significantly with actigraphically measured
TST and wake-after-sleep-onset. A cut-off score of five or more on the SDI summed
product score (sum of the products of the frequency and severity of each item) yielded
the best sensitivity, specificity, predictive values, and Youden’s Index.
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Conclusion: We suggest a clinical cut-off for the presence of disturbed sleep in
institutionalized dementia patients to be a SDI summed product score of five or more.
The results suggest that the SDI can be clinically useful for the identification of disrupted
sleep when administered by daytime staff in a nursing home context.
Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT03357328.
Keywords: dementia, sleep, proxy-rating, actigraphy, nursing home
INTRODUCTION
Sleep problems and disturbed nocturnal behavior constitute
important aspects of the behavioral and psychological symptoms
of dementia (BPSD) (1). In nursing homes, night-time
wandering, confusion, and related behaviors can increase
the risk of patient injuries, e.g., falling (2), and may cause
disturbances for other residents. Such behaviors are also
distressing and resource demanding for the staff (3).
As part of normal aging, characteristic changes in sleep and
circadian rhythmicity take place. These entail a reduction in sleep
duration and the proportion of slow wave sleep, as well as sleep
fragmentation and an increase in the frequency and duration
of daytime naps (4). Commonly, the sleep phase is advanced,
implying that older people tend to experience sleepiness earlier
in the evening and wake up earlier in the morning than desired.
Also, the prevalence of some primary sleep disorders, such as
sleep-disordered breathing, increases with age (5).
Sleep and circadian alterations are more frequent in patients
suffering from dementia than in normal aging, and studies
have provided estimates of disturbed sleep from 24% (6, 7) to
70% in dementia populations (8, 9). Brain systems involved
in sleep and wakefulness are often increasingly affected as
neurodegeneration progresses (10). Moreover, the causes of
disturbed sleep in dementia are multiple, and factors such
as inactivity, medications, and reduced exposure to social
interaction and reduced daylight exposure are all associated with
disturbed sleep (11–13).
Disruption of sleep and circadian rhythmicity have been
associated with increased agitation (14), depressive symptoms
(15–17), and cognitive impairment (15, 18) in people with
dementia. In addition, disturbed sleep has been identified
as an important cause of caregiver distress (19, 20) and of
institutionalization of patients suffering from dementia (21–23).
Detecting and treating disturbed sleep is of crucial importance
in relation to improving behavioral and mood related symptoms,
enhancing well-being, and reducing caregiver distress.
Assessing disturbed sleep in people with dementia is
challenging, as self-report may be unreliable and, in many cases,
unfeasible. Most et al. (24) demonstrated that even in the early
and middle stages of Alzheimer’s disease (AD), patients had
more objectively measured sleep problems compared to healthy
age-matched controls, however, the former group self-reported
fewer sleep problems. Hence, clinicians and researchers often
rely on proxy-rater instruments, where nurses or relatives answer
on behalf of the patient. Unfortunately, research suggests that
nursing home staff often provide unreliable and inaccurate
reports of their patients’ sleep when not using adequate
instruments (25–27). For example, using the sleep items of
the Cornell Scale of Depression in Dementia (CSDD) and the
Neuropsychiatric Inventory (NPI) in a nursing home population,
Blytt et al. (25) found that staff reported significantly fewer sleep
problems than measured by actigraphy. Their study suggested
that disturbed sleep may go largely undetected in the nursing
home population when measured by staff rated instruments with
only one or a few items. Meanwhile, using the comprehensive
21-items Circadian Sleep Inventory for Normal and Pathological
States (CSINAPS), completed by nursing home nurses, Hoekert
et al. (27) found only small-to-medium associations between
actigraphy parameters and scale items and subscales. However,
systematic observation of sleep behavior often requires that staff
frequently or continuously observe each patient across several
days (28, 29). Such time consuming and resource intensive
assessments are not necessarily feasible in a nursing home
context. Further, objective measures of sleep such as actigraphy
are rarely used in clinical contexts due to the cost of the
equipment and the time and skill needed to interpret the output.
Thus, identifying a relatively short questionnaire that more
accurately detect sleep problems in dementia populations has the
potential of providing caregiving staff with a clinically important
and more feasible tool.
To the authors’ knowledge, the Sleep Disorder Inventory
(SDI) (30) is the only short-form scale that exclusively focuses
on evaluating sleep in dementia populations. Tractenberg
and colleagues (30) have demonstrated appropriate convergent
validity (i.e., significant correlations with actigraphy) in a group
of home-dwelling participants suffering from AD. To date, the
SDI has not been validated for use in the nursing home context,
despite the need for clinically relevant and easy-to administer
sleep assessment tools in these settings.
Accordingly, the aim of the current study was to evaluate the
SDI in the nursing home context after adapting item wording
accordingly. Specifically, we aimed to: (i) assess the adapted SDI’s
internal consistency, (ii) investigate the convergent validity of the
adapted SDI against actigraphy, (iii) and suggest a clinical cut-off
for disturbed sleep in nursing home patients with dementia.
MATERIALS AND METHODS
Sample and Setting
This study used baseline data from a 6-months cluster-
randomized placebo-controlled trial, evaluating the effectiveness
of bright light treatment in people with dementia (the
DEM.LIGHT trial, ClinicalTrials.gov Identifier: NCT03357328).
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TABLE 1 | List of sample inclusion and exclusion criteria.
Participants were eligible if they: Patients were not included in the
study if they:
- were ≥60 years and in long-term
care (>4 weeks)
- had dementia in accordance with
DSM-5
- had either sleep/circadian rhythm
disturbances, BPSD as identified by
NPI-NH, or severely reduced ADL
function
- provided written informed consent if
the participant had capacity or, if
not, a written proxy informed
consent from a legally
authorized representative
- were blind or may otherwise not
benefit from light
- took part in another trial
- had a condition contra-indicated to
the intervention
- had an advanced, severe medical
disease/disorder and/or expected
survival less of than 6 months or
other aspects that could interfere
with participation
- were psychotic or had a severe
mental disorder
ADL, Activities of Daily Living; BPSD, Behavioral and Psychological Symptoms
of Dementia; DSM-5=Diagnostic and Statistical Manual of Mental Disorders-5;
FAST, Functional Assessment Staging; NPI-NH, Neuropsychiatric Inventory-Nursing
Home Version.
The trial was conducted in Norway from September 2017 to April
2018. We invited the Department of Health and Care, City of
Bergen, Norway, to participate in the study with eight eligible
nursing home dementia units (e.g., nursing homes that were not
involved in other trials or quality of care projects and that had
an architecture that allowed for ceiling light installment). See
Table 1 for inclusion and exclusion criteria.
Measurements
Researchers involved in the DEM.LIGHT trial supervised nurses
in the use of assessment tools. Only staff that knew the
patients well, i.e., the regular nursing staff, working directly with
the patients, completed the questionnaires. Daytime personnel
completed the questionnaires used in the present study, as
part of a larger data collection. The daytime nurses usually
convey information about patients to the attending physician
and are normally well-informed about nocturnal behavior of
the patients. In the present study, the questionnaires were
administered either the same week as the patients wore an
actigraph or the following week. The questionnaires were
completed once. Sociodemographic characteristics, medication
status, and diagnoses were collected from medical records.
The Mini-Mental State Examination (MMSE) (31) was used
to evaluate cognitive impairment at baseline. The total score
ranges from 0 to 30; zero to ten points corresponds to severe
dementia, 11–20 to moderate, 21–25 to mild dementia, 26–29
to questionable dementia, and 30 to no dementia (32). The
MMSE was administered the same week as the patients wore
the actigraph.
Sleep disturbance symptoms were assessed with the SDI,
which evaluates nocturnal behavior for the last 2 weeks (30).
The SDI is derived from the sleep item and its follow-up-
questions of the Neuropsychiatric Inventory (NPI) (33). The
NPI evaluates the frequency, severity, and caregiver distress
of several behavioral and psychological disturbances which
commonly occur in dementia, including disturbed sleep. The
questions pertain to the previous 4 weeks. Each item (e.g.,
agitation/aggression, anxiety, sleep) has a description to aid
determining whether and to what extent a disturbance occurs.
For the sleep item the description includes: “Does the patient
have difficulty sleeping? Is he/she up at night? Does he/she
wander at night, get dressed, or disturb your sleep?” Endorsement
of any of these behaviors elicits seven follow-up questions. The
NPI sleep item score is based on a single frequency and severity
rating for all the sleep disruption-related behaviors. The SDI was
developed by assigning a frequency (0–4), severity (0–3), and
caregiver distress (0–5) score to each of the follow-up questions
of the NPI sleep item (30).
The SDI was developed to be rated by the live-in caregivers
of home-dwelling seniors suffering from dementia. For the
DEM.LIGHT trial, the SDI was translated to Norwegian and
adapted to the nursing home context. Item 4 (“awakening you
during the night”) was changed into (“awakening at night”), in
order to take into account that patients may be awake at night
without engaging in any of the behaviors covered by other items
(e.g., wandering, getting out of bed). The translation process
adhered to standard guidelines to reach a cultural equivalence of
instruments (34). As some of the wording in the SDI was identical
to the NPI, which had already been translated to Norwegian (35),
we used the existing translations when possible. The SDI contains
eight items (see Supplementary Material), where the eighth item
asks about any additional information not captured by items 1–7.
Only items 1–7 were included in the total score.
In the original paper, Tractenberg et al. (30) calculated the
total SDI score as the average frequency multiplied by the
average severity. This total score has been used by other authors
adopting the scale (36, 37). When using this calculation, the total
score may however vary greatly depending on the distribution
of frequency and severity scores across items. For example,
having three frequently occurring symptoms (frequency = 4)
of mild severity (severity = 1) produces a higher total score
(=0.74, calculations provided in the Supplementary Material)
than having one frequently (frequency = 4) occurring symptom
of marked severity (severity = 3; = 0.25). Other authors have
therefore calculated the total score as the sum of the products of
the frequency and severity of each of the single items of the scale
(38, 39). This way of calculating the total score provides the same
total score for both of the scenarios outlined above (both = 12).
In the present study, both approaches to total score calculation
were investigated, where the former is referred to as the “SDI
average total score” and the latter is referred to as the “SDI
summed product score.” We also calculated summed frequency
as a general indicator of “overall disturbance” (referred to as the
“SDI summed frequency score”). Higher values on all of these
composite scores represent “worse sleep disturbance,” although
as noted above, these summaries are not linearly comparable. In
line with the original paper (30), mean frequency, severity, and
caregiver distress were also calculated.
The single sleep item from the nursing home version of
the NPI (NPI-NH) (35, 40) was investigated in relation to the
SDI. The NPI-NH asks about the previous 4 weeks. The NPI-
NH sleep item comes with a description similar to the NPI,
followed by six follow-up questions (including “other nighttime
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behaviors”). Previous studies have suggested a cut-off product
score of frequency (1–4) multiplied by severity (1–3) of ≥4 to
define the presence of sleep disturbance on this single item from
the NPI-NH (25, 41). In contrast to the SDI, the NPI-NH follow-
up questions do not ask about excessive daytime sleep (SDI item
7) or if the patient wake up during the night without engaging in
any specific behaviors (SDI item 4).
Sleep was objectively measured using the Actiwatch II (Philips
Respironics). Actigraphs are wrist-worn devices that can measure
activity across several days, and even weeks (42). The actigraphs
were placed on the dominant wrist, in accordance with previous
studies in this population (8, 25). Each 1-min epoch was scored
as either sleep or wake by the Actiware 6.0.9 (Philips Respironics)
software, based on activity from the two epochs immediately
preceding and following the relevant epoch. The threshold for
wakefulness was set to medium. Activity data were collected
for 7 days and patients had to complete at least five nights of
recordings to be included in the analyses. We initially planned
to score the actigraphic recordings manually, in line with a
premediated scoring protocol (25). However, it was challenging
to determine the start and end of the rest intervals. The event
buttons were not consistently pressed by the nursing home staff.
Additionally, many dementia patients have severely fragmented
sleep, thus, there were rarely clear indications of bedtime and
rise time in the actograms, normally indicated by a marked and
sustained decrease/increase in activity and/or light levels (25, 43).
These challenges are common in this population, and researchers
have typically solved these issues by setting a fixed rest interval
[e.g., (8, 14, 44–53)]. A range of rest intervals have been used
earlier and a fixed rest interval from 22:00 to 06:00 was chosen
for the present study, as it represents a sensible intermediate
of these. It was expected that the majority of patients would
be in bed by 22:00 and that the aforementioned interval would
overlap with the main sleep episode of most of the participants.
When using a fixed rest interval, some commonly reported
actigraphy outcomes become invalid, such as sleep onset latency
and early morning awakenings. Thus, the following actigraphy
outputs were extracted from the rest interval: Sleep efficiency
(SE, the percentage of time spent asleep in the rest interval),
total sleep time (TST), and wake-after-sleep-onset (WASO, the
time spent awake after sleep onset). While TST is a quantitative
measure of sleep, SE and WASO reflect mainly sleep quality,
although the latter parameters do not necessarily correspond
with subjectively reported sleep quality (54). The scores used for
SE, TST, and WASO were calculated as the mean value for all
nights of recorded actigraphy. These outputs are largely linear
in a fixed rest interval. In addition, the 24 h fragmentation index
was extracted, as an indication of the overall disturbance of the
sleep-wake rhythm across the day and night.
Having a SE of below 85% is often used as a cut-off for
identifying disrupted sleep in otherwise healthy populations
(55, 56). This corresponds to a TST of 6 h and 48min in the
fixed rest interval, which is close to the 7 h that is considered
normal in healthy populations (57). Dementia patients frequently
sleep during the day and some stay in bed for 12–13 h per
day (25), and it was therefore considered too strict to use
a cut-off of 6 h and 48min TST in the present study. Thus,
in agreement with Yesavage et al. (52), we used TST as the
indicator of overall sleep disturbance and TST values<6.0 h were
characterized as “disturbed” sleep, while those sleeping 6 h or
more were characterized as having “not disturbed” sleep. This
cutoff corresponds to a SE of 75% in the fixed rest interval
(22:00–06:00), a cutoff that has previously been used in dementia
populations (58).
Statistical Analyses
Statistical analyses were performed in SPSS for Windows, version
25.0. All data were analyzed for normality and non-normal data
were analyzed using non-parametric tests. Confidence intervals
(CIs) for medians were calculated using the Ratio Statistic in
SPSS. Due to the lack of distributional assumptions, the 95% CIs
for the Ratio Statistic represent approximations.
Missing Data and Imputation
There were some missing data on the SDI at baseline. Little’s
MCAR test was not significant (p =0.151), meaning that data
were missing completely at random (59). Imputations were thus
made by Expectation Maximization (EM) when questionnaires
were missing <20% of items (31 items from 11 patients, 2.2%
of all items). Three questionnaires were missing ≥20% and data
from these were excluded altogether from the analyses.
Internal Consistency
Internal consistency of the adapted SDI was evaluated using
Cronbach’s alpha (60), estimated as item-total correlations. A
Cronbach’s alpha of 0.7 and above is normally considered
acceptable (61). The internal consistency analyses were computed
separately for the frequency and severity ratings.
Convergent Validity
The strength of the relationships between the three different SDI
total scores, the single NPI sleep item (frequency × severity),
and actigraphic parameters were explored using Spearman
correlations. As TST and SE are perfect linear functions of each
other in a fixed rest interval, only TST,WASO, and fragmentation
index were included in this analysis.
Test Accuracy
Receiver operating characteristic (ROC) curves were calculated
for the actigraphy-based cut-off (“disturbed sleep” defined as a
TST of<6 h) against the SDI outcomes, in order to investigate the
diagnostic performance of each of the SDI composite scores (SDI
average total score, SDI summed product score, and SDI summed
frequency).We defined “disturbed sleep” as an average actigraphy
TST value of <6 h; this dichotomous variable was the outcome
in the ROC curve analysis (30, 52). The “area under the curve”
(AUC) score reflects the discriminatory ability of the test (62) or
SDI summary, in this case, for the outcome (disturbed sleep as
defined by TST). A high AUC score implies that the rate of true
positives is high and that the rate of false positives is low. AnAUC
score below 0.75 is not considered clinically useful (62).
Sensitivity, specificity, predictive values, and the rate of true
positives, false positives, true negatives, and false negatives were
calculated for the SDI summaries, to investigate which outcome
and which cut-off was the most clinically useful. Sensitivity refers
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to the proportion with the condition that get a positive test
result (true positives), while specificity refers to those who do
not suffer from the condition and that get a negative test result
(true negatives) (63). The positive predictive value refers to the
proportion of positive results that are true positives, while the
negative predictive value refers to the proportion of negative
results that are true negatives.
Youden’s Index
The Youden’s index (sensitivity + specificity-1) is a common
summary measure for the ROC curve and is used to determine
the most appropriate cut-off value for a scale (64–66). This index
incorporates sensitivity and specificity and the cut-off that yields
the highest Youden’s index value is regarded as the “optimal”
threshold value. The Youden’s Index was calculated for the SDI
summed product score and the SDI summed frequency score.
Ethical Approval and Consent to
Participate
Through conversations with the physician at each nursing
home, patients who were most likely able to provide informed
consent were identified. The researchers endeavored to inform all
participants about the study in an adapted way, and continuously
evaluated the capacity to provide consent. Most patients were not
able to provide consent. In these cases, the patient’s legal guardian
was contacted directly. After being approached by a phone call,
they received a letter by postal mail containing all relevant
information about the aims, proceedings, and ethical approval of
the trial, after which they gave a presumed informed consent on
behalf of the patient. In giving a presumed consent, the patient’s
guardian was instructed to consider what the patient would have
wished for in this situation, not what they themselves believed
was most pertinent. Across the study period, the researchers were
sensitive to any expressions of discomfort or protests from the
participants; and considered this as withdrawal of consent. The
study was approved by the Regional Ethics Committee (REC
South East 2016/2246).
RESULTS
A total of 69 participants were enrolled, of whom 68% were
women, mean age was 83.5 (SD 7.1), and mean MMSE was 6.4
(SD 6.7). Descriptive statistics and diagnoses are provided in
Table 2. Figure 1 shows the full inclusion and exclusion of study
participants leaving 62 with actigraphy recordings over at least 5
days and 65 with completed SDIs. A total of 59 patients had both
completed SDI and had sufficient actigraphy recordings.
Sleep Assessed With SDI
The SDI scores were not normally distributed, with the majority
of patients obtaining low scores. Therefore, the median was used
to summarize the group, instead of the mean (Table 3). In all,
19 patients (32%) had a total score of 0. The median of the SDI
average total score was 0.06 and the median of the SDI summed
product score and the SDI summed frequency score was 3.00.
Mean frequency was 0.43, mean intensity was 0.14, and mean
TABLE 2 | Descriptive statistics for the 69 patients.
Age (mean, SD) 83.5 (7.1)
Female (%) 68.0%
Mini mental state examination sum score,
mean (SD) (n = 56)
6.4 (6.7), median
4.0
Dementia diagnoses, n (%)
Alzheimer’s disease (AD) 38 (55.1)
Mixed AD and vascular dementia 0
Lewy body dementia 1 (1.4)
Other dementia 2 (2.9)
Vascular dementia 4 (5.8)
Frontotemporal dementia 0
Parkinson’s dementia 0
Unknown dementia 21 (30.4)
No diagnosis¤ 3 (4.4)
Neuropsychiatric inventory (NPI) (n = 69)
NPI total score, median (25th−75th percentile) 21.0 (6.0–42.0)
Sleep item score, median (25th−75th percentile) 0.0 (0.0–4.0)
Sleep item score ≥ 4, n (%) 18 (26.1)
Sleep item score 0, n (%) 38 (55.1)
Total number of medications (mean, SD) 6.7 (2.8)
Number of psychotropic medications* (mean, SD) 2.9 (1.3)




*All medications with an ATC code starting with N.
§All medications with an ATC code starting with N05C.
¤These patients were still included as their scores on the Mini Mental State Examination
and the Functional Assessment Staging suggest moderate and severe dementia. In
addition, clinically trained researchers concluded that they with high probability suffered
from dementia according to the DSM-5 criteria.
staff distress was 0.29. All SDI-based scores had a wide range,
reflecting heterogeneity in the sample.
The most frequent behavior was waking up at night,
happening at least once a week (i.e., endorsed by the staff) for
46% of the patients (Table 4). Getting up during the night was
endorsed for 34% of the patients and 31% engaged in wandering
or inappropriate activities during the night. The three items
reflecting these behaviors were also the most distressing to the
nursing personnel. One third of the patients were reported to
sleep excessively during the day at least once a week, but this
behavior caused less distress among staff.
Sleep Assessed With Actigraphy
The actigraph results were based on recordings including a mean
of 7.6 (SD 1.4, range 5–14) nights. The median sleep length (TST)
within the rest interval (i.e., at night) was 6 h 19min (95% CI 5 h
23 min−6 h 41min) and the median SE was 79% (95% CI 69–
84) (Table 5). The time spent awake after sleep onset (WASO)
was normally distributed and had a mean of 1 h 9min (95% CI
57 min−1 h 20min). The 24 h fragmentation index had a mean
of 93.2 (95% CI 88.0–98.3). All actigraphy outcomes had a wide
range, reflecting heterogeneity in the population.
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FIGURE 1 | A flow chart of the inclusion process. Allocation to intervention group and placebo group omitted here as only baseline data are used in present study.
TABLE 3 | Median values for the SDI outcomes for the 59 patients that had both SDI and actigraphy data, all of which had non-normal distributions.
SDI outcome (possible min-max score) Median 25th percentile 75th percentile Min-max 95% CI of median*
SDI average total (0–12) 0.06 0.00 1.84 0.00–6.12 0.04–0.57
SDI summed product (0–84) 3.00 0.00 18.00 0–60 2.00–9.00
SDI summed frequency (0–28) 3.00 0.00 11.00 0–22 2.00–7.00
SDI mean frequency (0–4) 0.43 0.00 1.57 0–3 0.29–1.00
SDI mean severity (0–3) 0.14 0.00 0.86 0–2 0.14–0.57
SDI mean distress (0–5) 0.29 0.00 1.43 0–4 0.00–0.86
SDI, Sleep Disorder Inventory.
*CI for medians were calculated with the Ratio Statistic in SPSS, which provide varying coverage, but always more than 95%.
Internal Consistency of the SDI
Cronbach’s alpha for the adapted SDI was 0.82 for the
frequency ratings and 0.87 for the severity ratings. The item-
total correlations varied across items and were below 0.3
for the frequency of item 7 (excessive sleep during the
day;0.22), the severity of item 6 (wake up too early;0.23) and
the severity of item 7 (excessive sleep during the day;0.25).
Removing these items caused only negligible increases of
alpha. Daytime sleep propensity became more severe with
increasing AD severity (67), hence the daytime sleep item
(item 7) provided relevant clinical information; thus even if
item-total correlations are lowest for these items/ratings, they
are a clinically-essential component of the instrument and
its scores.
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TABLE 4 | The endorsement of each SDI item (frequency ≥2), percentage rated
as being moderately to markedly severe (severity ≥2), and percentage rated as
moderately to extremely distressing (staff distress ≥3), in accordance with











Difficulty falling asleep 25.43 16.95 13.56
Getting up during the night 33.90 27.12 25.42
Wandering, pacing or getting involved
in inappropriate activities at night
30.51 23.73 25.42
Awakening at night 45.76 30.51 23.73
Awakening at night, dressing, and
planning to go out, thinking that it is
morning and time to start the day
11.86 8.48 6.78
Awakening too early in the morning
(earlier than is his/her habit)
8.48 3.39 1.70
Sleeping excessively during the day 33.90 13.56 3.39
SDI, Sleep Disorder Inventory.
Frequency ratings: 0 = not present; 1 = less than once per week; 2 = 1–2 times per
week; 3 = several times per week but less than every day; 4 = once or more per day
(every night). Severity ratings: 0 = not present; 1 = mild; 2 = moderate; 3 = marked.
Staff distress ratings: 0 = not at all; 1 = minimally; 2 = mildly; 3 = moderately; 4 =
severely; 5 = very severely/extremely (30).
TABLE 5 | Actigraphy variables for the 59 participants with complete SDI and
actigraphic recordings based on a mean of 7.6 days.
Mean (SD) Range 95 % CI§
TST night 379.10 (290.86–423.00)* 123.00–463.40 323.57–401.00
SE 79.00(60.60–88.13)* 25.63–96.54 68.59–83.54
WASO 68.47 (43.72) 3.00–212.71 57.08–79.87
24 h fragmentation
index
93.15 (19.58) 61.03–141.63 88.04–98.25
SE, sleep efficiency; TST, total sleep time; WASO, wake after sleep onset.
*Non-normal data presented as medians with the 25th and 75th percentile in parentheses.
§CI for medians were calculated with the Ratio Statistic in SPSS, which provide varying
coverage, but always more than 95%.
Convergent Validity: SDI Compared to
Actigraphy and NPI-NH
Table 6 shows the Spearman correlation coefficients between
different SDI variables and the actigraphy parameters. For
TST at night, all SDI outcomes had a significant and
moderate correlation (minimum −0.40 and maximum −0.44).
As expected, greater SDI scores were associated with lower TST
(resulting in a negative correlation), higher WASO, and higher
scores on the single NPI-NH sleep item (positive correlations).
The SDI summaries did not correlate significantly with the 24 h
fragmentation index.
Test Accuracy
As noted, we defined “disturbed sleep” to be actigraphy-derived
TST of <6 h for the ROC curve analysis (1 = TST at night <6 h,
0 = TST at night ≥6 h). Twenty-seven patients had a TST below
TABLE 6 | The correlation coefficients (Spearman’s rho) for the SDI outcomes
against actigraphy outcomes and the NPI-NH sleep item.








SDI average total −0.431* 0.389* 0.216 0.746*
SDI summed
product
−0.432* 0.402* 0.216 0.751*
SDI summed
frequency
−0.436* 0.395* 0.213 0.754*
Mean frequency −0.436* 0.395* 0.213 0.754*
Mean severity −0.403* 0.369* 0.195 0.749*
Mean distress −0.408* 0.372* 0.160 0.755*
NPI-NH, Neuropsychiatric Inventory—nursing home version; SDI, Sleep Disorder
Inventory; TST, total sleep time; WASO, wake after sleep onset.
*Correlations were significant at the 0.01 level (2-tailed).
TABLE 7 | The ROC output for the SDI summaries against the 6 h actigraphy
TST cut-off.
95% CI






Total SDI average total 0.771 0.064 0.000 0.646 0.895
Total SDI summed
product
0.777 0.063 0.000 0.653 0.900
Total SDI summed
frequency
0.780 0.062 0.000 0.659 0.901
CI, confidence interval; ROC, Receiver operating characteristic; SDI, Sleep Disorder
Inventory; TST, Total sleep time.
6 h, and 32 patients had a TST of 6 h or more. We evaluated
how the three SDI summaries performed against this standard
(Table 7). The AUC scores were above 0.75 for all three SDI
summaries, indicating that all are clinically useful. The scores
were almost equivalent, however, the SDI summed product score
and the SDI summed frequency score both had slightly higher
AUC scores than the SDI average total score, with AUC scores
of 0.78, 0.78, and 0.77, respectively.
The sensitivity, specificity, predictive values, and ratios of true
positives, false positives, true negatives, and false negatives were
calculated for each level of the SDI summed product score (range
1–84) (Table 8) and the SDI summed frequency score (range 1–
28) (Table 9). For both the SDI summed product score and the
SDI summed frequency score, Youden’s index peaked at cut-off
scores of 5–6 and the results are presented for values 1–10. The
sensitivity, specificity, and Youden’s Index of the SDI average
total score (not shown) were all worse than the two best AUC
performing summaries.
Comparing the SDI summed product score and the SDI
summed frequency score, the former achieved the highest
Youden’s index (0.485 compared to 0.480). These values were
obtained for both a cut-off of ≥5 and a cut-off ≥6, for both the
SDI summed product score and the SDI summed frequency score.
For the SDI summed product score, these cut-offs had a sensitivity
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TABLE 8 | The sensitivity, specificity, positive and negative predictive values, and the rate of true positives, false positives, true negatives, false negatives, and the
Youden’s Index for each value of the SDI summed product score (sum of frequency × severity).
SDI summed product score Sensitivity (%) Specificity (%) PPV (%) NPV(%) TP FP TN FN Youden’s Index
≥1 85 47 58 79 23 17 15 4 0.321
≥2 85 47 61 81 23 15 17 4 0.321
≥3 78 63 64 77 21 12 20 6 0.403
≥4 74 72 69 77 20 9 23 7 0.460
≥5 70 78 73 76 19 7 25 8 0.485
≥6 70 78 73 76 19 7 25 8 0.485
≥7 63 81 74 72 17 6 26 10 0.443
≥8 63 81 74 72 17 6 26 10 0.443
≥9 63 81 74 72 17 6 26 10 0.443
≥10 59 84 76 71 16 5 27 11 0.437
Total n = 59. FN, false negative; FP, false positive; NPV, negative predictive value; PPV, positive predictive value; SDI, Sleep Disorder Inventory; TN, true negative; TP, true positive.
TABLE 9 | The sensitivity, specificity, positive, and negative predictive values, and the rate of true positives, false positives, true negatives, false negatives, and the
Youden’s Index for each value of the SDI summed frequency score.
SDI summed frequency score Sensitivity (%) Specificity (%) PPV (%) NPV (%) TP FP TN FN Youden’s Index
≥1 85 47 58 78 23 17 15 4 0.321
≥2 85 53 61 81 23 15 17 4 0.383
≥3 78 63 64 77 21 12 20 6 0.403
≥4 70 75 70 75 19 8 24 8 0.454
≥5 67 81 75 74 18 6 26 9 0.480
≥6 67 81 75 74 18 6 26 9 0.480
≥7 63 84 77 73 17 5 27 10 0.474
≥8 59 84 76 71 16 5 27 11 0.477
≥9 56 84 75 69 15 5 27 12 0.400
≥10 48 88 77 67 13 4 28 14 0.357
Total n = 59. FN, false negative; FP, false positive; NPV, negative predictive value; PPV, positive predictive value; SDI, Sleep Disorder Inventory; TN, true negative; TP, true positive.
of 70%, a specificity of 78%, a positive predictive value (PPV)
of 73% and a negative predictive value (NPV) of 76%. For the
SDI summed frequency score, these cut-offs yielded a sensitivity
of 67%, a specificity of 81%, a PPV of 75%, and a NPV of 74%.
DISCUSSION
The aim of the present study was to validate the SDI in a nursing
home context and to determine a clinically useful cut-off score
on the SDI to identify sleep disturbance in this population. The
analyses showed that the SDI had high internal consistency and
convergent validity.
Even though two items had low item-total correlation,
they were not excluded because they minimally affected the
overall internal consistency and thus may provide important
clinical information. Three different ways of summarizing
the SDI correlated significantly with the actigraphy outcomes
TST at night and WASO, with medium-strength associations.
Considering frequency, severity, and staff distress separately,
frequency had the strongest association to these actigraphy sleep
variables. The SDI summaries did not correlate with 24 h sleep
fragmentation. Although the SDI contains one item pertaining
to daytime sleep, the total score did not seem to reflect the
fragmentation of the sleep-wake rhythm across the day and
night. The ROC curve analyses indicated that the SDI average
total score, the SDI summed product score, and the SDI total
frequency score led to correct predictions of disrupted sleep (yes
and no) about 78% of the time (95% CI about 65–90%), which
is considered to be “clinically useful” (62). The SDI summed
product score, using a cut-off for disturbed sleep of five or more
or six or more had the highest Youden’s Index values. Both cut-
offs yielded a sensitivity of 70%, a specificity of 78%, a positive
predictive value (PPV) of 73% and a negative predictive value
(NPV) of 76% for predicting disturbance defined as <6 h in TST
defined by actigraphy. The SDI summed frequency score had the
highest AUC score, however, obtained a slightly lower maximum
Youden’s index. The maximum Youden’s index on this summary
was also obtained by both a cut-off of five or more and six
or more, yielding a sensitivity of 67%, a specificity of 81%, a
PPV of 75%, and a NPV of 74%. Because it is important to be
as sensitive to disrupted sleep as possible, we believe that the
SDI summary providing the highest sensitivity should be used
(i.e., the SDI summed product score), and also that the lower
cut-off (≥5) should be used. Thus, we suggest a clinical cut-off
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for the presence of disturbed sleep in institutionalized dementia
patients to be a SDI summed product score of five or more. Even
though the SDI was developed for home-dwelling seniors and
their caregivers (30), the present study demonstrates that the SDI
can be clinically useful for the identification of sleep disturbance
when administered by daytime staff in a nursing home context.
The present finding of the clinical utility of a proxy-rated sleep
tool stands in contrast to the findings by Blytt et al. (25), where
the sleep items of the CSDD and the sleep item from the NPI-
NH underreported sleep problems when compared to actigraphy
parameters. Other than using different subjective sleep outcomes,
the discrepancy between the present results and the results from
Blytt et al. (25) may in part be explained by differences in the
choice of actigraphy-based cut-offs for defining disturbed sleep.
In the present study, disturbed sleep was defined as sleeping
<6 h between 22:00 and 06:00, corresponding to a SE of 75%
or less. More conservatively, Blytt et al. (25) defined disturbed
sleep as having <85% SE, in each participants’ individual rest
interval (based on light, activity, and event marker information
in the actogram, indicating bedtime and wake time), which is a
common cut-off for defining disturbed sleep (55, 56), albeit in
normal populations.
In the original paper by Tractenberg et al. (30), they defined
a rest interval from 20:00 to 08:00. To avoid the inclusion of
time spent out of bed, we instead used a rest interval from
22:00 to 06:00, reflecting a more realistic interval in this specific
population. The use of a common night-time interval for all
participants in our sample reflects a period when patients are
expected to be in bed. Using a wider rest interval might have
increased the variability of SDI ratings across wards or nurse
raters, as problematic night-time behavior in one ward could,
for example, be classified as afternoon or evening restlessness in
a ward with later bed time. Conversely, a narrow rest interval
may have excluded time when many patients were in bed and
asleep, as nursing home patients spend substantial time in
bed (25).
In the original study, Tractenberg et al. (30) found a higher
prevalence of symptoms than in the present study. However,
in their study, participants were recruited based on sleep
complaints, while disrupted sleep was only one of several
optional inclusion criteria in the present study. Also, bed-sharing
caregivers [as in (30)] are likely to be more sensitive to nocturnal
behavior than nursing home staff, as staff generally do not
attend to the patients at night unless they get up or call for
assistance. Further, sleep difficulties or nocturnal behavior might
not be reported consistently in the patient records and may not
always be conveyed to the day shift staff. This might explain
the low clinical cut-off suggested in the present study: A sum
frequency of five is low, given that the maximum score is 84.
This suggests that even this slight subjective impression of sleep
disturbance among patients on the nursing home staff, may
reflect a significant disruption of sleep. However, we did observe
that the distributions of SDI summary scores were skewed toward
the low-scoring end of the continuum, and 44% of the sample
would be qualified as “sleep disturbed” using the cut-off of 5, as
compared with 46% characterized as “sleep disturbed” using the
clinical and objective TST cut-off of <6 h.
The present study suggests that the SDI, rated by daytime
staff, may be used to detect sleep problems in institutionalized
dementia patients. The cut-off score identified can be used as
a means of identifying patients for inclusion in clinical trials of
sleep interventions. To treat disturbed sleep, it is necessary to
identify the underlying cause. In line with this, the SDI can serve
as a screening tool to identify patients who struggle with sleep
problems, and form the basis for a more deliberate mapping
of sleep problems. For example, sleep disturbance caused by
nocturia requires a different treatment than sleep disordered
breathing. Hoeckert et al. (27) used the CSINAPS scale, that
specifically asked about snoring, breathing problems and unusual
movements. These items were rarely endorsed despite high
prevalence of sleep disordered breathing and periodic leg
movements in dementia patients (68), reflecting the need tomore
deliberately evaluate these symptoms. Importantly, the use of
objective measurements presents a challenge as many patients
struggle with tolerating the equipment (69). Thus, deliberate and
continuous observation of patients that struggle with sleep, for
example patients identified by the SDI, is probably necessary
in order to identify the specific underlying problems. However,
the routine use of validated sleep scales may encourage the
awareness among staff of how clinically relevant sleep problems
in these patients are, increasing staff sensitivity to the importance
of detecting signs of poor sleep as a significant component in
understanding the patient’s overall behavioral problems.
Strengths and Limitations
The majority of the included participants provided good quality
actigraphy data for a minimum of 5 nights (mean 7.6 nights).
The patients who agreed to wear the actigraph generally wore
it continuously until it was collected by the researchers. Because
the presence of disturbed sleep was not a required criterion for
inclusion, the participants exhibited a wide range in scores on
the sleep parameters. The present study demonstrated the utility
of the SDI in a heterogeneous sample that is representative of
institutionalized patients suffering from dementia.
One important limitation is the choice of an actigraphy-based
outcome as the reference against which the SDI was validated.
Wrist actigraphy has been shown to be a reliable method of
assessing sleep in different clinical populations, compared to
the “gold standard” of polysomnography and observation (70),
including nursing home patients with severe dementia (69).
However, studies have demonstrated that actigraphy has low
specificity (poor wake detection) (71) and that it overestimates
sleep in people with very disturbed sleep (8, 72). Thus,
actigraphy has acknowledged weaknesses in terms of detecting
wakefulness, hence the correlations between SDI summaries
and actigraphic data found in the present investigation might
represent overestimates. Another limitation is the suboptimal
use of the event marker and consequently the use of a fixed
rest interval. Future studies should secure a robust indication of
bedtime and rise time to obtain more accurate reports of each
participants’ sleep.
Further, even though the ROC curve analysis revealed a
clinically useful cut-off for the SDI summaries, the AUC scores
of 0.77 (SDI average total) and 0.78 (SDI summed product,
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SDI summed frequency) still correspond to a relatively low
discriminatory power (62). The confidence intervals for the
AUC scores were quite wide and ranged from about 0.65,
corresponding to no clinical value, to 0.90, corresponding to high
clinical value (62). This indicates somewhat uncertainty about
value of the SDI summaries. We thus suggest that the findings
should be replicated in a larger sample.
The correlation between the SDI summed product score
and actigraphically-measured TST was 0.43, corresponding to
a moderate correlation (73), but also shows that there is
significantly residual variance in TST not captured by the SDI.
In fact, the amount of shared variability was <20% (0.43 ×
0.43 = 0.185) and over 80% of the variability in SDI scores
was not explained by the TST value. As the actigraphy-based
TST was a summary across a minimum of 5 days (mean 7.7),
and the SDI is a summary across 2 weeks, there was not an
exact temporal overlap between the two measures. The SDI
covered the last 14 days and was completed in the same week
that the actigraph was worn by the participants. Hence, the
temporal overlap between the two measures was incomplete, and
thus the SDI includes behavior not captured by the actigraph.
Importantly, there is however a well-documented discrepancy
between subjective and objective measures of sleep (74, 75), and
this discrepancy is probably a strong contributor to the residual
variance in actigraphically measured TST in the present study,
in addition to the lack of temporal correspondence. Further,
there is a lot more complexity to “disrupted sleep” than what
is captured by actigraphically assessed TST alone, which is, at
its core, a reflection of immobility. However, both outcomes
(actigraphy-measured TST and the SDI summary) were used
as approximations of general sleep disturbance, where both can
serve as indicators that a more deliberate evaluation of sleep
is warranted.
The completion of the SDI was part of a larger data
collection project and all questionnaires were completed by
nurses during the day. Few nurses are at work during the night
and our data collection corresponds with clinical assessments
in nursing homes, which are normally performed during the
day in collaboration with the nursing home physician. The
night time staff are obliged to write reports and to note in
the medical record if clinically relevant events have taken place
during night shifts. It is also common that staff share information
orally during handover. Thus, daytime staff should be informed
about any nocturnal events. It would however be preferable
to obtain both night and daytime staff reports on the SDI.
Nevertheless, the fact that we did achieve an AUC score of
0.78 and significant correlations between the SDI and actigraphy
demonstrates that daytime staff have significant information
about patients’ behavior outside their own shift. It also suggests
that the usual procedure of administering tests during the day
is feasible also with the SDI, provided adequate communication
between the night and day shift.
While the SDI summed product score and the SDI summed
frequency score both led to the same cut-off value (≥5) for
identifying disrupted sleep, the sample size of the present study
was relatively small and confirmatory studies in larger samples
are warranted. We did not interrogate the specific diagnoses
or prescriptions of sedatives of the participants included in the
trial, and there may be important differences among those with
AD, dementia with Lewy bodies, and vascular dementia. Future
studies should address these issues.
CONCLUSION
Overall, the results of the present study showed that the scores
on the proxy-rated Sleep Disorder Inventory correspond well
to objectively measured sleep disruption (defined as a TST<6 h,
corresponding to a SE<75%) in institutionalized dementia
patients, using a clinical cut-off of a summed product score
of five or more. The present results should be interpreted
with caution bearing in mind that actigraphy was used as
the reference outcome measure of sleep. Even though the SDI
seems to identify patients with disturbed sleep successfully, some
patients suffering from disturbed sleep may still go undetected.
The recommended cut-off score (≥5) is low, suggesting that
only a slight clinical impression of disrupted sleep may reflect
significant sleep disruption. Nursing home staff should be vigilant
to document any signs of sleep problems among patients at all
times. The SDI appears to be useful as a screening tool to identify
patients with probable sleep problems. However, determining
the cause of the disrupted sleep normally would require a more
deliberate approach, such as continuous observation and/or
polysomnografic/polygraphic recordings.
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